StockWatch
·

Mankind Pharma Ltd

BSE: 543904

values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-4.781.1K2.2K3.4KQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Margin Trend

percentage
OPM %NPM %
2.8614.8626.8538.85Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
PeriodQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25
INCOME
Revenue3.0K+14.8%2.6K-1.9%2.6K+0.9%2.6K+2.7%2.5K+19.5%2.1K-11.3%2.4K-5.3%2.5K
Other Income33.96-73.2%126.70+124.2%56.52-27.2%77.67+20.9%64.22-70.7%219.32+214.1%69.82-34.0%105.76
Total Income3.0K+10.7%2.7K+0.7%2.7K+0.1%2.7K+3.1%2.6K+11.1%2.3K-4.9%2.5K-6.4%2.6K
EXPENSES
Expenditure2.2K+18.1%1.9K-9.7%2.1K-2.8%2.2K+2.4%2.1K+10.2%1.9K-1.3%1.9K+4.1%1.9K
Tax198.08+166.2%74.40+33.3%55.82-15.1%65.73-18.8%80.90+74.8%46.29-57.1%107.87-35.8%168.01
PROFIT
PBT756.57-4.0%788.01+56.0%505.29-3.7%524.63+6.3%493.66+15.1%428.75-18.2%524.25-32.0%770.45
Net Profit558.49-21.7%713.61+58.8%449.47-2.1%458.90+11.2%412.76+7.9%382.46-8.1%416.38-34.4%634.43
KEY METRICS
OPM %31.33%-3.37pp34.70%+8.31pp26.39%-0.18pp26.57%+0.09pp26.48%+4.05pp22.43%+15.42pp7.01%-15.81pp22.82%
NPM %18.63%-7.72pp26.35%+9.64pp16.71%-0.37pp17.08%+1.24pp15.84%-0.46pp16.30%-0.58pp16.88%-5.98pp22.86%
EPS13.53-21.7%17.29+58.8%10.89-2.1%11.12+11.2%10.00+7.9%9.27-10.4%10.35-31.2%15.04

Corporate Events

Board MeetingMANKIND
2026
10Aug

Board Meeting

The Board of Directors considered and approved the appointme…

BSE Filing
Board MeetingMANKIND
2026
4Aug

Board Meeting

The 35th Annual General Meeting ("AGM") of the Members of Ma…

BSE Filing
Board MeetingMANKIND
2026
30Jul

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing
Board MeetingMANKIND
2026
11Jul

Board Meeting

The Board of Directors considered and approved the proposal …

BSE Filing
Board MeetingMANKIND
2026
11Jul

Board Meeting

The Board of Directors considered and approved the proposal …

BSE Filing
Board MeetingMANKIND
2025
14Apr

Board Meeting

Constitution of a ‘Structural Integration Committee’, Incorp…

BSE Filing
Board MeetingMANKIND
2024
5Nov

Board Meeting

consider and approve the unaudited standalone and consolidat…

BSE Filing